Poly Medicure Limited Schedules Additional Investor Meeting for March 30, 2026
Poly Medicure Limited continues its investor engagement activities with the announcement of a new one-on-one meeting with Front Wave Research LLP scheduled for March 30, 2026. This adds to the company's existing meeting schedule that includes sessions with Avendus Spark and Quantum Advisors Private Limited on March 24, 2026, while maintaining full regulatory compliance under SEBI guidelines.
*this image is generated using AI for illustrative purposes only.
Poly medicure Limited has announced scheduled one-on-one meetings with analysts and investors, as per regulatory filings under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed both BSE Limited and National Stock Exchange of India Limited about these investor interactions.
March 24, 2026 Meeting Schedule
The company had previously scheduled two virtual one-on-one meetings for March 24, 2026:
| S. No. | Investor | Meeting Date | Time | Venue | Format |
|---|---|---|---|---|---|
| 1. | Avendus Spark | Tuesday, 24th March, 2026 | 02:30 P.M. | Virtual | One-on-one |
| 2. | Quantum Advisors Private Limited | Tuesday, 24th March, 2026 | 05:30 P.M. | Virtual | One-on-one |
Latest Meeting Addition
In the latest regulatory filing dated March 25, 2026, Poly Medicure Limited has scheduled an additional investor meeting:
| S. No. | Investor | Meeting Date | Time | Venue | Format |
|---|---|---|---|---|---|
| 1. | Front Wave Research LLP | Monday, 30th March, 2026 | 03:30 P.M. | Virtual | One-on-one |
The company noted that confirmation for this meeting was received on shorter notice, hence the intimation is being made at a shorter notice.
Meeting Cancellation
The company had also announced the cancellation of a previously scheduled meeting with TCG Asset Management:
| Investor | Original Meeting Date | Time | Venue | Format | Status |
|---|---|---|---|---|---|
| TCG Asset Management | Friday, 20th March, 2026 | 02:30 P.M. | Virtual | One-on-one | Cancelled |
Regulatory Compliance
Poly Medicure Limited has emphasized that all schedules are subject to changes due to exigencies on the part of analysts, investors, or the company. The company has specifically stated that no unpublished price sensitive information will be shared during these meetings, ensuring compliance with regulatory requirements.
The latest communication was signed by Avinash Chandra, Company Secretary (M. No. A32270), and digitally authenticated on March 25, 2026, at 15:57:48 +05'30'. The company maintains its registered office at 232 B, 3rd Floor, Okhla Industrial Estate, Phase-III, New Delhi - 110 020.
Historical Stock Returns for Poly Medicure
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.97% | +2.43% | +6.22% | -31.61% | -38.00% | +59.36% |
What strategic announcements or business updates might Poly Medicure be preparing to share given the increased investor engagement activity?
How could the outcomes of these investor meetings influence Poly Medicure's stock price and trading volume in the coming weeks?
Will Poly Medicure expand its investor outreach program to include more institutional investors following these initial meetings?
20
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
